Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
TREM2, ERK/p38, and Experimental Autoimmune Uveitis
2026-09-03
The reference study identifies TREM2 as an anti-inflammatory regulator of retinal microglia in experimental autoimmune uveitis, linking its activity to suppression of ERK/p38 signaling. By combining mouse disease models, BV2 microglial perturbation, immune phenotyping, and RNA sequencing, the work connects microglial state control with retinal vascular leakage and systemic Th1, Th17, and Treg imbalance.
-
MK-1775 (Wee1 kinase inhibitor): Lab Guide
2026-09-03
A scenario-based guide to using MK-1775 (Wee1 kinase inhibitor), SKU A5755, in cell-cycle, viability, proliferation, and combination assays. It connects Wee1 biology with practical formulation, storage, control design, and interpretation of arrest versus cell death.
-
Hoechst 33342 in Fibroblast Senescence Research
2026-09-02
A translational guide to using Hoechst 33342 nuclear staining as a quantitative anchor for dermal fibroblast senescence, mitochondrial quality, and pterostilbene response studies.
-
E-4031: hERG Blocker Workflow Guide
2026-09-02
E-4031 provides a controlled way to model hERG-mediated repolarization defects across patch clamp, action-potential, MEA, and cardiac organoid assays. This guide connects concentration planning, QT interval analysis, proarrhythmic modeling, and troubleshooting to practical preclinical workflows.
-
Sulfo-NHS-Biotin: Mechanism and Workflow
2026-09-01
Sulfo-NHS-Biotin is a water-soluble, amine-reactive protein labeling reagent for covalent biotinylation of lysine side chains and N-terminal amines. Its short 13.5 Å spacer supports affinity workflows and intact-cell surface labeling, while its random amine reactivity requires controls for labeling density and protein activity.
-
SCH772984 ERK1/2 Inhibitor Workflow
2026-09-01
Build a mutation-aware ERK1/2 inhibition workflow around SCH772984, from phospho-signaling validation to clonogenic radiosensitivity and xenograft studies. The guide also shows how to translate nasopharyngeal carcinoma ferroptosis findings into testable, clearly bounded ERK-pathway experiments.
-
Acridine Orange hydrochloride Protocol Guide
2026-08-31
Acridine Orange hydrochloride is a membrane-permeable fluorescent nucleic acid dye for differential DNA and RNA or single-stranded nucleic acid staining in cytochemical and flow-based workflows. It is suitable for cell cycle analysis, apoptosis detection, and nucleic acid profiling, but should not be selected for non-nucleic-acid targets or protocols requiring long-term storage of prepared solutions.
-
SGC-CBP30 for Reliable Cell Assays
2026-08-31
Learn how SGC-CBP30 (SKU A4491), a selective CREBBP/EP300 bromodomain inhibitor, can be incorporated into viability, proliferation, and cytotoxicity workflows. This scenario-based guide connects biochemical potency, practical formulation, storage, and lung adenocarcinoma research without confusing mechanistic perturbation with a universal assay control.
-
Estradiol, ER Stress, and CD4+ T-Cell Recovery
2026-08-30
This reference study shows that estradiol restores splenic CD4+ T-lymphocyte function after hemorrhagic shock by engaging ERα and GPR30 while suppressing endoplasmic reticulum stress. Its receptor-selective pharmacology provides a useful framework for distinguishing classical and non-genomic estrogen signaling in post-shock immune dysfunction.
-
Z-VAD-FMK: Mapping Cell-Death Decisions
2026-08-29
A mechanistic and translational guide to using Z-VAD-FMK to distinguish caspase-dependent apoptosis from inflammatory and necroptotic cell death, with practical considerations for experimental design.
-
Azilsartan Medoxomil: Sustained AT1 Blockade
2026-08-28
The 2017 mini-review linked azilsartan medoxomil’s persistent AT1-receptor interaction with its pharmacokinetic profile, blood-pressure efficacy, and tolerability relative to established ARBs. Its central contribution is a translational interpretation of receptor-binding and clinical evidence, while also emphasizing that improved blood-pressure control has not yet been conclusively tied to lower mortality.
-
QRICH1–HMGB1 Signaling in HBV Fibrosis
2026-08-28
A 2025 Immunobiology study identifies QRICH1 as an endoplasmic reticulum stress effector that amplifies HBV-associated HMGB1 translocation and secretion in hepatocytes. The work connects QRICH1-dependent transcriptional regulation with SIRT6-linked HMGB1 acetylation, providing a mechanistic framework for understanding inflammatory progression toward hepatic fibrosis.
-
(+)-Bicuculline: Practical Lab Protocol
2026-08-27
This guide explains how to prepare, store, and quality-control (+)-Bicuculline for experiments involving GABAA receptor antagonism, GABAergic signaling pathway analysis, and related neuronal assays. It is intended as a research-use workflow aid, not as clinical guidance, and product-specific observations should not be generalized beyond the stated models.
-
Cisplatin as a DNA-Repair Stress Test
2026-08-27
Cisplatin (CDDP) is more than a cytotoxic endpoint: it can function as a controlled stress test of DNA repair competence. This article translates recent nasopharyngeal carcinoma findings into practical assay design, orthogonal readouts, and model-selection principles.
-
HOXC8, Caspase-1, and NSCLC Pyroptosis
2026-08-26
The reference study identifies HOXC8 as a transcriptional suppressor of CASP1 that protects non-small cell lung carcinoma cells from caspase-1-dependent pyroptosis. Its central innovation is linking HOXC8 to HDAC1/2 recruitment at the CASP1 promoter, establishing an epigenetic mechanism that connects tumor-cell survival with inflammatory cell-death control.